April is Bowel Cancer awareness month. Menarini Diagnostics are proud to offer key bowel antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Colon and rectal cancers are the 4th most diagnosed cancer in the UK, with approximately 12% of all new cancer cases classified as bowel cancer, contributing to approximately 10% of cancer deaths yearly (1). Menarini Diagnostics offer key antibodies that may aid identification of their respective proteins by IHC in FFPE tissues. Take a look at the antibody factsheet linked below which details more information on the antibodies we offer.
(1) Cancer Research UK (2015), http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer